Who is sponsoring NCT02190903?

NCT02190903 is sponsored by University of Pennsylvania.

What drugs are being tested in NCT02190903?

Interventions in NCT02190903: General endotracheal anesthesia, Regional (spinal) Anesthesia.

What condition does NCT02190903 study?

NCT02190903 studies Postoperative Complications, Hip Fracture, Delirium.

Is NCT02190903 still recruiting?

NCT02190903 is currently completed. Last updated 27 July 2018.

Are results published for NCT02190903?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2018-07-27 · How we verify

NCT02190903

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Randomized Controlled Trial To Assess Risk of Delirium in Older Adults Undergoing Hip Fracture Surgery With Spinal or General Anesthesia

Completed NA Results posted Last updated 27 July 2018

What this trial tests

NA trial testing General endotracheal anesthesia in Postoperative Complications in 15 participants. Completed in 1 April 2015.

Timeline

1 October 2013

Primary endpoint
1 April 2015

1 April 2015

Quick facts

Lead sponsor	University of Pennsylvania
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	15
Start date	1 October 2013
Primary completion	1 April 2015
Estimated completion	1 April 2015
Sites	1 location across United States

Drugs / interventions tested

General endotracheal anesthesia
Regional (spinal) Anesthesia

Conditions studied

Postoperative Complications — all drugs for Postoperative Complications →
Hip Fracture — all drugs for Hip Fracture →
Delirium — all drugs for Delirium →

Sponsor

University of Pennsylvania

Who can join

18 and older, any sex, with Postoperative Complications or Hip Fracture. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Number of Participants With Postoperative Delirium After Hip Fracture Surgery
Time frame: Up to 5 days post hip fracture surgery
Delirium will be assessed by the Confusion Assessment Method Instrument (CAM), a validated method of assessing delirium based on the presence of both (1) an acute onset of signs and symptoms with a fluctuating course AND (2) inattention; PLUS (3) disorganized thinking OR (4) an altered level of consciousness.

Sponsor's own description

This pilot project will address the gaps in knowledge regarding the effect of anesthetic technique on the risk of delirium through an adequately-powered trial employing standardized regimens for treatment and outcome assessment to test the hypothesis that use of spinal versus general anesthesia decreases the risk of delirium after hip fracture surgery.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Anaesthesia for hip fracture surgery in adults.
Guay J, Parker MJ, Gajendragadkar PR, Kopp S. · · 2016 · cited 114× · PMID 26899415 · DOI 10.1002/14651858.cd000521.pub3
Pilot Randomized Controlled Trial of Spinal Versus General Anesthesia for Hip Fracture Surgery.
Neuman MD, Mehta S, Bannister ER, Hesketh PJ, et al · · 2016 · cited 8× · PMID 27996117 · DOI 10.1111/jgs.14373

Verify or expand the search:

Other University of Pennsylvania trials

Trials by the same sponsor.

NCT06081153 — Mechanistic Clinical Trial of PCSK9 Inhibition for AAA · EARLY_PHASE1 · not yet recruiting
NCT07415772 — Effect of cTBS on Startle and TMS-evoked BOLD · NA · not yet recruiting
NCT07489430 — DaxibotulinumtoxinA for Blepharospasm · Phase 2 · not yet recruiting
NCT07463131 — Negative Income Tax Trial · NA · not yet recruiting
NCT06645769 — Na-Phenylbutyrate VAscular Trial · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02190903 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Pennsylvania
Last refreshed: 27 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02190903.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing